- Sector: Healthcare
- Industry: Biotechnology
- Full Time Employees: 44
- Headquarters: Research Triangle Park, North Carolina
- Founded: 2008
- http://www.g1therapeutics.com
- One week later:
Thursday, May 18, 2017
G1 Therapeutics (GTHX) began trading on the Nasdaq on 18 May 2017
G1 Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in the United States.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment